Danaher Co. (NYSE:DHR) Stock Holdings Reduced by Rockland Trust Co. (2024)

Rockland Trust Co. reduced its position in Danaher Co. (NYSE:DHR - Free Report) by 64.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,263 shares of the conglomerate's stock after selling 67,762 shares during the quarter. Rockland Trust Co.'s holdings in Danaher were worth $9,305,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. Acadian Asset Management LLC boosted its stake in shares of Danaher by 7.6% in the 3rd quarter. Acadian Asset Management LLC now owns 7,915 shares of the conglomerate's stock valued at $1,962,000 after buying an additional 558 shares during the period. Regal Investment Advisors LLC boosted its stake in shares of Danaher by 57.7% in the 3rd quarter. Regal Investment Advisors LLC now owns 4,636 shares of the conglomerate's stock valued at $1,150,000 after buying an additional 1,697 shares during the period. Clearbridge Investments LLC boosted its stake in shares of Danaher by 2.2% in the 3rd quarter. Clearbridge Investments LLC now owns 285,489 shares of the conglomerate's stock valued at $70,830,000 after buying an additional 6,212 shares during the period. LPL Financial LLC boosted its stake in shares of Danaher by 6.6% in the 3rd quarter. LPL Financial LLC now owns 284,672 shares of the conglomerate's stock valued at $70,627,000 after buying an additional 17,519 shares during the period. Finally, Rice Partnership LLC boosted its stake in shares of Danaher by 18.1% in the 3rd quarter. Rice Partnership LLC now owns 39,583 shares of the conglomerate's stock valued at $9,821,000 after buying an additional 6,075 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

Shares of NYSE:DHR traded up $6.40 during trading on Friday, reaching $254.96. The company had a trading volume of 6,839,526 shares, compared to its average volume of 3,070,856. The firm has a market capitalization of $188.85 billion, a price-to-earnings ratio of 43.21, a price-to-earnings-growth ratio of 3.80 and a beta of 0.85. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The stock's fifty day moving average price is $254.46 and its 200 day moving average price is $245.44. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $269.11.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company's revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.36 earnings per share. As a group, equities research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date of this dividend is Friday, June 28th. Danaher's payout ratio is currently 18.31%.

Analyst Ratings Changes

Several research firms recently weighed in on DHR. HSBC upgraded Danaher from a "hold" rating to a "buy" rating and boosted their target price for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. TD Cowen boosted their target price on Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a research note on Wednesday, April 24th. Citigroup boosted their target price on Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a research note on Wednesday, April 24th. Jefferies Financial Group began coverage on Danaher in a research note on Monday, June 3rd. They set a "buy" rating and a $295.00 target price for the company. Finally, Bank of America boosted their target price on Danaher from $258.00 to $270.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 24th. Five research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $269.29.

Get Our Latest Stock Report on DHR

Insider Buying and Selling

In related news, CEO Rainer Blair sold 47,175 shares of the company's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares of the company's stock, valued at $28,908,273.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Rainer Blair sold 47,175 shares of the company's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares of the company's stock, valued at $28,908,273.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the company's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total value of $1,000,040.00. Following the transaction, the senior vice president now directly owns 29,830 shares in the company, valued at approximately $7,457,798.30. The disclosure for this sale can be found here. Insiders have sold 148,783 shares of company stock valued at $37,536,717 over the last quarter. Company insiders own 11.10% of the company's stock.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

• Five stocks we like better than Danaher
• Consumer Staples Stocks, Explained
• McDonald's Stock: Balancing Value and Innovation
• How to Use the MarketBeat Excel Dividend Calculator
• MarketBeat Week in Review – 6/17 - 6/21
• How to Find Undervalued Stocks
• Sarepta Therapeutics Stock Soars on FDA Approval

Should you invest $1,000 in Danaher right now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here